All Brands Owned by AstraZeneca PLC

Is AstraZeneca a British or Swedish company?
AstraZeneca is a British-Swedish company. It was formed in 1999 by merging Sweden's Astra AB with the UK's Zeneca Group. Legally it is a UK public limited company headquartered in Cambridge, England, though it retains major operations in Sweden.

Is AstraZeneca publicly traded?
Yes. AstraZeneca PLC trades primarily on the London Stock Exchange under ticker AZN, where it is one of the largest FTSE 100 companies, and it maintains a secondary listing on Nasdaq under the same ticker.

When was AstraZeneca founded?
AstraZeneca was formed in 1999 through the Astra-Zeneca merger. Its roots extend to 1913, when Astra was founded in Sweden, and to Zeneca's 1993 spin-off from Imperial Chemical Industries.

Who leads AstraZeneca?
Pascal Soriot has been chief executive officer since 2012. He is credited with rebuilding the company's pipeline, rejecting Pfizer's 2014 takeover bid, and driving its current position as a top-tier oncology and rare disease company.

What is AstraZeneca's market position?
AstraZeneca is a top-10 global pharmaceutical company with $58.7 billion in 2025 revenue. It is a global leader in oncology and operates major franchises in CVRM, respiratory, and rare disease, with 16 blockbuster medicines and approximately 94,000 employees.

What are AstraZeneca's biggest products?
Tagrisso, Farxiga, Imfinzi, Lynparza, Soliris, Ultomiris, and Symbicort are among its largest products. Oncology alone generated $25.6 billion in 2025, and the company counts 16 medicines with annual sales above $1 billion.